152 related articles for article (PubMed ID: 8905121)
1. Cytochromes P450 and UDP-glucuronosyl-transferases as hepatocellular autoantigens.
Obermayer-Straub P; Manns MP
Baillieres Clin Gastroenterol; 1996 Sep; 10(3):501-32. PubMed ID: 8905121
[TBL] [Abstract][Full Text] [Related]
2. Cytochromes P450 and uridine triphosphate-glucuronosyltransferases: model autoantigens to study drug-induced, virus-induced, and autoimmune liver disease.
Manns MP; Obermayer-Straub P
Hepatology; 1997 Oct; 26(4):1054-66. PubMed ID: 9328334
[TBL] [Abstract][Full Text] [Related]
3. Cytochrome P450 enzymes and UDP-glucuronosyltransferases as hepatocellular autoantigens.
Obermayer-Straub P; Manns MP
Mol Biol Rep; 1996; 23(3-4):235-42. PubMed ID: 9112234
[TBL] [Abstract][Full Text] [Related]
4. Target proteins in human autoimmunity: cytochromes P450 and UDP- glucuronosyltransferases.
Obermayer-Straub P; Strassburg CP; Manns MP
Can J Gastroenterol; 2000 May; 14(5):429-39. PubMed ID: 10851284
[TBL] [Abstract][Full Text] [Related]
5. Viral induction of autoimmunity: mechanisms and examples in hepatology.
Manns MP; Obermayer-Straub P
J Viral Hepat; 1997; 4 Suppl 2():42-7. PubMed ID: 9429209
[TBL] [Abstract][Full Text] [Related]
6. Cytochrome P450 1A2 is a hepatic autoantigen in autoimmune polyglandular syndrome type 1.
Clemente MG; Obermayer-Straub P; Meloni A; Strassburg CP; Arangino V; Tukey RH; De Virgiliis S; Manns MP
J Clin Endocrinol Metab; 1997 May; 82(5):1353-61. PubMed ID: 9141515
[TBL] [Abstract][Full Text] [Related]
7. Expression of autoantibodies to specific cytochromes P450 in a case of disulfiram hepatitis.
Eliasson E; Stål P; Oksanen A; Lytton S
J Hepatol; 1998 Nov; 29(5):819-25. PubMed ID: 9833921
[TBL] [Abstract][Full Text] [Related]
8. Human cytochrome P450 2E1 is a major autoantigen associated with halothane hepatitis.
Bourdi M; Chen W; Peter RM; Martin JL; Buters JT; Nelson SD; Pohl LR
Chem Res Toxicol; 1996; 9(7):1159-66. PubMed ID: 8902272
[TBL] [Abstract][Full Text] [Related]
9. Autoantibodies and defined target autoantigens in autoimmune hepatitis: an overview.
Dalekos GN; Zachou K; Liaskos C; Gatselis N
Eur J Intern Med; 2002 Aug; 13(5):293-303. PubMed ID: 12144908
[TBL] [Abstract][Full Text] [Related]
10. Enzymes as target antigens of liver-specific autoimmunity: the case of cytochromes P450s.
Bogdanos DP; Dalekos GN
Curr Med Chem; 2008; 15(22):2285-92. PubMed ID: 18781950
[TBL] [Abstract][Full Text] [Related]
11. Hepatotropic viruses and autoimmunity 1997.
Manns MP
J Viral Hepat; 1997; 4 Suppl 1():7-10. PubMed ID: 9097272
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies and autoantigens in autoimmune hepatitis: important tools in clinical practice and to study pathogenesis of the disease.
Zachou K; Rigopoulou E; Dalekos GN
J Autoimmune Dis; 2004 Oct; 1(1):2. PubMed ID: 15679907
[TBL] [Abstract][Full Text] [Related]
13. Two cytochromes P450 are major hepatocellular autoantigens in autoimmune polyglandular syndrome type 1.
Clemente MG; Meloni A; Obermayer-Straub P; Frau F; Manns MP; De Virgiliis S
Gastroenterology; 1998 Feb; 114(2):324-8. PubMed ID: 9453493
[TBL] [Abstract][Full Text] [Related]
14. A major CYP2D6 autoepitope in autoimmune hepatitis type 2 and chronic hepatitis C is a three-dimensional structure homologous to other cytochrome P450 autoantigens.
Sugimura T; Obermayer-Straub P; Kayser A; Braun S; Loges S; Alex B; Lüttig B; Johnson EF; Manns MP; Strassburg CP
Autoimmunity; 2002 Dec; 35(8):501-13. PubMed ID: 12765476
[TBL] [Abstract][Full Text] [Related]
15. Antigenic targets in tienilic acid hepatitis. Both cytochrome P450 2C11 and 2C11-tienilic acid adducts are transported to the plasma membrane of rat hepatocytes and recognized by human sera.
Robin MA; Maratrat M; Le Roy M; Le Breton FP; Bonierbale E; Dansette P; Ballet F; Mansuy D; Pessayre D
J Clin Invest; 1996 Sep; 98(6):1471-80. PubMed ID: 8823314
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies against CYP2D6 and other drug-metabolizing enzymes in autoimmune hepatitis type 2.
Mizutani T; Shinoda M; Tanaka Y; Kuno T; Hattori A; Usui T; Kuno N; Osaka T
Drug Metab Rev; 2005; 37(1):235-52. PubMed ID: 15747502
[TBL] [Abstract][Full Text] [Related]
17. High levels of autoantibodies against drug-metabolizing enzymes in SLA/LP-positive AIH-1 sera.
Shinoda M; Tanaka Y; Kuno T; Matsufuji T; Matsufuji S; Murakami Y; Mizutani T
Autoimmunity; 2004; 37(6-7):473-80. PubMed ID: 15621574
[TBL] [Abstract][Full Text] [Related]
18. Anti-cytochrome P450 autoantibodies in drug-induced disease.
Beaune PH; Lecoeur S; Bourdi M; Gauffre A; Belloc C; Dansette P; Mansuy D
Eur J Haematol Suppl; 1996; 60():89-92. PubMed ID: 8987248
[TBL] [Abstract][Full Text] [Related]
19. Autoantibodies to adrenal cytochrome P450 antigens in isolated Addison's disease and autoimmune polyendocrine syndrome type II.
Seissler J; Schott M; Steinbrenner H; Peterson P; Scherbaum WA
Exp Clin Endocrinol Diabetes; 1999; 107(3):208-13. PubMed ID: 10376448
[TBL] [Abstract][Full Text] [Related]
20. Autoantibodies directed against the UDP-glucuronosyltransferases in human autoimmune hepatitis.
Fabien N; Desbos A; Bienvenu J; Magdalou J
Autoimmun Rev; 2004 Jan; 3(1):1-9. PubMed ID: 14871643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]